Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2021-12-08 Director's Dealing
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
110年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors, supervisors, and major shareholders. It lists the number of shares held, pledged shares, and related percentages. This type of disclosure is typical of insider shareholding notifications or director dealings. There is no indication of financial results, management discussion, or meeting materials. The document is not a report or announcement of a report but a factual disclosure of insider shareholdings. Therefore, the most appropriate classification is Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives.
2021-12-08 Chinese
110年11月法人說明會簡報 — 172020211117E001.pdf
Investor Presentation Classification · 95% confidence The document is titled '2021 Investor Conference 11/18/2021' and includes an agenda with topics such as '2021 Q1-Q3 Operating Results', 'Future Operation Strategy', and 'Corporate Social Responsibility (CSR)'. It contains detailed financial data including consolidated income statements for Q1-Q3 2021, quarterly revenue comparisons over the past 5 years, and other operational metrics. The presence of a Q&A session and instructions for microphone use indicate this is a transcript or presentation of a live event. The content is consistent with an investor presentation focusing on financials, strategy, and market position rather than a formal regulatory filing or full annual/interim report. The length (15,000 characters) and detailed financial data support this classification. Therefore, the document is best classified as an Investor Presentation (IP).
2021-11-17 Chinese
110年11月法人說明會簡報 — 172020211117M001.pdf
Investor Presentation Classification · 95% confidence The document is titled as a "法人說明會" which translates to "Investor Conference" or "Investor Presentation" for the company Standard Chem & Pharm CO., LTD. It is dated November 18, 2021, and includes detailed financial data such as consolidated income statements for the first three quarters of 2021, revenue comparisons over multiple years, and future operational strategies. The content includes forward-looking statements, operational results, and strategic outlooks. The length is substantial (15,000 characters), and the document contains detailed financial and strategic information typically presented to investors. There is no indication that this is a full annual report (10-K), audit report, or earnings release. It is not a transcript of a call but rather a prepared presentation. Therefore, the document fits best into the category of an Investor Presentation (IP).
2021-11-17 Chinese
110年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting (法人說明會), including date, time, location, and links to presentation materials. It specifically mentions a '法人說明會' which translates to 'investor presentation' or 'analyst meeting'. The document is short (712 characters) and contains no financial statements or detailed financial analysis, only metadata and links to presentation files. Therefore, it is best classified as an Investor Presentation (IP).
2021-11-17 Chinese
110年第3季海外子公司投資
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data related to investment holdings in overseas subsidiaries, including investment amounts, shareholding percentages, and recognized investment gains or losses for a specific period (110年3季, which corresponds to the third quarter of the year 110 in the Taiwanese calendar). The presence of substantive financial data and analysis for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is short (894 characters), but it contains actual financial figures rather than just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-11-15 Chinese
110年第3季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial figures concerning investments in mainland China by a Taiwanese listed company. It includes specific financial data such as capital amounts, investment methods, cumulative investment amounts, recognized investment gains or losses, and regulatory approval limits. The document is relatively short (1411 characters) and focuses on investment details rather than a full financial report or announcement. It does not appear to be an announcement of a report publication, nor a certification or a general regulatory filing. The content aligns with a regulatory disclosure related to investment activities, which typically falls under Regulatory Filings (RNS) as it does not fit the other more specific categories like Annual Report, Interim Report, or Capital/Financing Update. Therefore, the best classification is Regulatory Filings (RNS).
2021-11-15 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.